MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNTZhan Zhang, Carla Grandori, Aaron N. Chang et al.|Cell Cycle|2009Cited by 284
Functional genomics identifies therapeutic targets for MYC-driven cancerMasafumi Toyoshima, Carla Grandori, Heather L. Howie et al.|Proceedings of the National Academy of Sciences|2012Cited by 252
MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle 8:2756-2768Zhan Zhang, Carla Grandori, Hong Sun et al.|Unknown|2009Cited by 3
Abstract C135: Therapeutic targets for MYC-driven cancer.Masafumi Toyoshima, Carla Grandori, Heather L. Howie et al.|Molecular Cancer Therapeutics|2011Cited by 0